Evaluation of Recombinant Eilat Virus as a Viral Vector for Expression of the Heterologous Antigen Genes Canine Parainfluenza Virus HN and F Protein Genes and Rabies G protein Gene

Project: Other project

StatusFinished
Effective start/end date6/1/156/1/17

Funding

  • Boehringer Ingelheim Pharmaceuticals: $41,915.00